Incidence is the most informative descriptive epidemiological indicator when addressing multiple sclerosis (MS) etiological research. The analysis of women-to-me (sex) ratio has recently been regarded as an alternative approach to disclose incidence changes in time, space and person and can therefore be of great interest. Sex ratio is regarded as a robust epidemiological indicator which not only provides clues to disease etiology, but also allows for data comparison across different populations. However, the question as to whether this is true or not is indeed complex.
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Ajdacic-Gross and von Wyl 1 report being in favour of this relationship in that risk factors for increased MS incidence, for example, cigarette smoking habit or vitamin D serum levels, are also drivers of sex ratio modulation. Higher MS sex ratios have actually been reported in populations featuring increased MS incidence linking the role of female-specific risk factors to the disease increased burden.
Conversely, Magyari and Koch-Henriksen 2 warn about methodological issue starting with the computation of sex ratio, which does not contemplate stratifying for sex-specific incidences. More recent studies on at-high-risk populations reveal sex ratio stability over time. [3] [4] [5] [6] Recent MS incidence studies almost inevitably include the 'sex ratio methodology', with a focus on 'year-of-birth cohorts' analysis besides reporting sex ratio by clinical onset or diagnosis. This approach is intended to minimize confounding related to sex differences in time to diagnosis and age of onset and is an attempt at disclosing patterns suggesting the impact of sex-specific early-life exposures in determining the disease risk later in life. Such evidence was reported for the first time for over 27,000 Canadian MS patients. 5 The sex ratio by year of birth increased from 1.9 in 1930 to 3.2 in 1980, with an estimated 0.2% yearly MS increase among women. Year of birth was therefore regarded as a significant predictor for MS sex ratio. However, an interdependency obviously exists between the distribution by sex at disease onset or diagnosis and at birth, given that the study population remains selected based on diagnosis, no matter which age investigations focus on. Whether by-year-of-birth sex ratio reflects the true sex ratio at individuals' birth is therefore only an assumption, and inference on sex-specific early life events must be taken cautiously.
Not surprisingly, when 'age-period-cohort' analysis is applied to sex-ratio investigations to disentangle potential confounders, such as the effect of age, of period linked to historical circumstances and of birth cohort, both incidence and sex-ratio changes are primarily associated with birth cohort and not with the more informative effect, that is, period. Age-related collinearity between cohort and period effects makes it impossible to discern their respective contribution to the risk.
Moreover, what 'birth-cohort' effect indeed implies, whether pre-natal or perinatal exposures or early childhood events, is seldom addressed.
Methodological issues (e.g. study population size), clinical phenotype (relapsing vs progressive onset), paediatric versus adult disease and degree of access to medical care which has dramatically changed between men and women over decades can bias the interpretation of sex ratio-based evidence. Increased sex ratio reflects increased disease onset among women and not a decrease among men, 7 most predominantly in relapsingremitting MS 8 and in more recent calendar periods. 9 Examples of other indicators of MS incidence are age at onset 10 and latitude. 8 MS incidence depends on a dynamic etiological pathway of which sex ratio is only one piece of a complex mosaic.
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